Ravindra Uppaluri, MD, PhD, lead investigator of the phase 3 KEYNOTE-689 trial (NCT03765918), highlights the potential of pembrolizumab (Keytruda; Merck) to improve outcomes following head and neck ...

The probe will work alongside Ferronova’s FerroTrace to improve the detection of cancerous lymph nodes during surgery - AdobeStock Backed by the federal government’s Economic Accelerator (AEA) Ignite ...

to improve the detection of cancerous lymph nodes during surgery, reducing the need for extensive procedures that often lead to life-threatening complications and life-long side-effects for survivors.

The probe will work alongside Ferronova's iron-oxide nanoparticle formulation (FerroTrace) to improve the detection of cancerous lymph nodes during surgery, reducing the need for extensive ...

The $405,050 project focuses on the development of a probe that will work alongside Ferronova’s iron-oxide nanoparticle formulation (FerroTrace) to enhance the detection of cancerous lymph nodes ...

The probe will work alongside Ferronova's iron-oxide nanoparticle formulation (FerroTrace) to improve the detection of cancerous lymph nodes during surgery, reducing the need for extensive ...

1 Department of Radiology, Shaoxing Second Hospital Medical Community General Hospital, Shaoxing, China 2 Department of Medical Oncology, Shaoxing Second Hospital Medical Community General Hospital, ...